Prostate biopsy: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Diagram_showing_a_transperineal_prostate_biopsy_CRUK_473.svg|Diagram showing a transperineal prostate biopsy | |||
File:Targeted_MRI-US_fusion_prostate_biopsy_at_UCLA.jpg|Targeted MRI-US fusion prostate biopsy at UCLA | |||
File:Post_Transperineal_Biopsy.jpg|Post Transperineal Biopsy | |||
</gallery> | |||
Latest revision as of 04:13, 18 February 2025
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined for the presence of cancer. It is typically performed when the result from a PSA blood test rises to a level that could indicate prostate cancer.
Procedure[edit]
A prostate biopsy is performed by a urologist, who may use ultrasound guidance. The patient is usually given a local anesthetic. The procedure involves inserting a needle into the prostate gland, which is located in front of the rectum, and removing a small sample of tissue. The procedure is usually performed in the doctor's office and takes about 10 minutes.
Risks[edit]
Like any procedure, a prostate biopsy carries risks. These may include bleeding, infection, and difficulty urinating. There is also a small risk that the biopsy will miss a cancer that is present in the prostate.
Results[edit]
The tissue samples are sent to a laboratory, where a pathologist examines them under a microscope. If cancer cells are found, the pathologist will also determine the Gleason score, which helps predict the aggressiveness of the cancer.
Follow-up[edit]
If the biopsy results show cancer, the patient and doctor will discuss treatment options. These may include surgery, radiation therapy, hormone therapy, or active surveillance.


